340570.KQ T&L Co. Ltd
- Market cap
- KRW 377B
- P/E
- 7.6x
- P/B
- 1.68x
- ROE
- 32.5%
- Dividend yield
- 1.60%
- Fundamental score
- 3.2/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 340570.KQ undervalued?
Graham number340570.KQ trades 24.7% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
T&L Co. Ltd fundamental analysis
15 of 22 checks passedROE 2/2
High return on equity (32.5%), above 20%.
ROA 1/1
Return on assets (28.7%) is above the industry median (6.2%).
Profit Consistency 2/2
Profitable for 9 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-58.7%) is not above the 5-year average (14.0% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-58.7%) is below the industry median (0.5%).
Revenue Growth 2/2
Revenue grew 26.2% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 14,835.1x against interest expense, well covered.
PE vs Market 1/1
PE (7.6x) is below the market median (11.3x).
PE vs Industry 0/1
PE (7.6x) is above the industry median (7.6x).
PBV 0/1
Price to book (1.7x) is above the industry median (0.7x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 12.8, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.54, growth is cheap.
Dividend Yield 1/2
Dividend yield (1.6%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 1/2
Dividends paid without a cut of more than 10% for 7 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 15.9%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
T&L Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.
Full company profileT&L Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
T&L Co. Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 26.6B | 26.3B | 32.6B | 40.6B | 71.9B | 81.6B | 115B | 175B | 164B | 202B |
| Gross Profit | 9.44B | 10.7B | 13.1B | 15.8B | 30.5B | 34.2B | 45.2B | 75.5B | 72.4B | 105B |
| Operating Income | 5.75B | 5.27B | 7.67B | 9.59B | 22.3B | 24.3B | 30.8B | 57.0B | 46.4B | 86.4B |
| EBITDA | - | - | - | - | - | 27.7B | 35.9B | 66.2B | 52.5B | 99.3B |
| Net Income | 4.80B | 4.66B | 7.29B | 10.0B | 19.6B | 21.1B | 27.4B | 46.4B | 38.1B | 72.8B |
| EPS | 750 | 728 | 1,138 | 1,235 | 2,410 | 2,616 | 3,399 | 5,749 | 2,375 | 4,549 |
| Balance Sheet | ||||||||||
| Total Assets | 33.6B | 36.5B | 43.3B | 79.5B | 98.3B | 117B | 142B | 197B | 217B | 253B |
| Total Liabilities | 9.81B | 9.29B | 10.1B | 7.50B | 8.22B | 10.9B | 12.6B | 25.6B | 15.9B | 29.0B |
| Shareholders' Equity | 23.8B | 27.2B | 33.2B | 72.0B | 90.1B | 106B | 130B | 171B | 201B | 224B |
| Cash & Short-term Investments | 1.96B | 2.77B | 4.90B | 34.6B | 36.6B | 31.6B | 47.3B | 75.1B | 73.7B | 36.5B |
| Total Debt | 5.33B | 3.35B | 2.71B | 18.3M | - | - | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | - | 6.39B | 7.83B | 9.34B | 19.0B | 15.4B | 32.6B | 46.6B | 37.7B | 60.5B |
| Capital Expenditure | - | 2.81B | 4.28B | 2.98B | 16.0B | 16.0B | 14.9B | 16.4B | 18.1B | 14.8B |
| Free Cash Flow | - | - | 4.11B | 5.90B | 2.99B | -598M | 17.7B | 30.2B | 19.6B | 45.6B |
| Ratios | ||||||||||
| ROE | 20.2% | 17.1% | 21.9% | 14.0% | 21.7% | 19.9% | 21.2% | 27.1% | 18.9% | 32.5% |
| ROA | 14.3% | 12.8% | 16.8% | 12.6% | 19.9% | 18.0% | 19.3% | 23.5% | 17.5% | 28.7% |
| Net Profit Margin | 18.1% | 17.7% | 22.3% | 24.7% | 27.2% | 25.9% | 23.8% | 26.5% | 23.2% | 36.0% |
| Debt to Equity | 0.22x | 0.12x | 0.08x | 0.00x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
T&L Co. Ltd dividends
- Dividend yield
- 1.60%
- Forward dividend
- 750.00 KRW
- Payout ratio
- 15.9%
- Ex-dividend date
- Dec 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 6.05B | 378 | 15.9% |
| 2024 | KRW 4.44B | 550 | 9.6% |
| 2023 | KRW 3.63B | 450 | 13.2% |
| 2022 | KRW 3.25B | 403 | 15.4% |
| 2021 | KRW 1.63B | 200 | 8.3% |
| 2020 | KRW 1.28B | 157 | 12.7% |
| 2019 | KRW 1.28B | 200 | 17.6% |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Aug 6, 2026.
Who owns T&L Co. Ltd
- Insiders 43.11%
- Institutions 5.75%
- Public & others 51.15%
- Shares outstanding 15.9M
- Free float 9.06M
T&L Co. Ltd company profile
- Company name
- T&L Co. Ltd
- Ticker
- 340570.KQ
- ISIN
- KR7340570001
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 250
- Fiscal year end
- December
- Address
- 767, Sinsu-ro, Yongin-si, South Korea, 16827
- Phone
- 82 3 1323 3113
- Website
- tnl.co.kr
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.
T&L Co. Ltd management
1- Mr. Yoon-So ChoiChief Executive Officer · born 1959